Validation of results from knowledge discovery: mass density as a predictor of breast cancer.

Published

Journal Article

The purpose of our study is to identify and quantify the association between high breast mass density and breast malignancy using inductive logic programming (ILP) and conditional probabilities, and validate this association in an independent dataset. We ran our ILP algorithm on 62,219 mammographic abnormalities. We set the Aleph ILP system to generate 10,000 rules per malignant finding with a recall >5% and precision >25%. Aleph reported the best rule for each malignant finding. A total of 80 unique rules were learned. A radiologist reviewed all rules and identified potentially interesting rules. High breast mass density appeared in 24% of the learned rules. We confirmed each interesting rule by calculating the probability of malignancy given each mammographic descriptor. High mass density was the fifth highest ranked predictor. To validate the association between mass density and malignancy in an independent dataset, we collected data from 180 consecutive breast biopsies performed between 2005 and 2007. We created a logistic model with benign or malignant outcome as the dependent variable while controlling for potentially confounding factors. We calculated odds ratios based on dichomotized variables. In our logistic regression model, the independent predictors high breast mass density (OR 6.6, CI 2.5-17.6), irregular mass shape (OR 10.0, CI 3.4-29.5), spiculated mass margin (OR 20.4, CI 1.9-222.8), and subject age (β = 0.09, p < 0.0001) significantly predicted malignancy. Both ILP and conditional probabilities show that high breast mass density is an important adjunct predictor of malignancy, and this association is confirmed in an independent data set of prospectively collected mammographic findings.

Full Text

Duke Authors

Cited Authors

  • Woods, RW; Oliphant, L; Shinki, K; Page, D; Shavlik, J; Burnside, E

Published Date

  • October 2010

Published In

Volume / Issue

  • 23 / 5

Start / End Page

  • 554 - 561

PubMed ID

  • 19760292

Pubmed Central ID

  • 19760292

Electronic International Standard Serial Number (EISSN)

  • 1618-727X

Digital Object Identifier (DOI)

  • 10.1007/s10278-009-9235-3

Language

  • eng

Conference Location

  • United States